Quinn Opportunity Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Electronic Arts
EA
|
+$152M |
| 2 |
Netflix
NFLX
|
+$69.4M |
| 3 |
HOLX
Hologic
HOLX
|
+$50.7M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$48.7M |
| 5 |
JHG
Janus Henderson
JHG
|
+$43.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PGRE
Paramount Group
PGRE
|
+$16M |
| 2 |
Cytokinetics
CYTK
|
+$14.7M |
| 3 |
ECHO
EchoStar
ECHO
|
+$13.2M |
| 4 |
Fair Isaac
FICO
|
+$12.4M |
| 5 |
Viking Therapeutics
VKTX
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 31.86% |
| 2 | Consumer Discretionary | 15.78% |
| 3 | Healthcare | 11.2% |
| 4 | Technology | 10.25% |
| 5 | Consumer Staples | 8.96% |
Similar funds
Quinn Opportunity Partners's Q4 2025 Portfolio in Review
As of Q4 2025, Quinn Opportunity Partners held 421 positions worth $2.37B, up 68% from $1.41B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Quinn Opportunity Partners deployed $955M of net new capital in Q4 2025, opening 90 new positions and adding to 94 existing holdings. Its largest new stake was Hologic: 693,600 shares worth $51.7M.
By sector, the portfolio is most concentrated in Communication Services at 32% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Cytokinetics, an estimated $14.7M trimmed.
- Quinn Opportunity Partners's largest Q4 2025 buy was Hologic: 693,600 shares worth $51.7M.
- Quinn Opportunity Partners added most to Electronic Arts in Q4 2025, an estimated $152M increase.
- Quinn Opportunity Partners's biggest Q4 2025 reduction was Cytokinetics, cutting an estimated $14.7M.
- Quinn Opportunity Partners fully exited Paramount Group in Q4 2025, selling an estimated $16M.
- Quinn Opportunity Partners's ten largest holdings make up 35% of its $2.37B portfolio in Q4 2025.
- Quinn Opportunity Partners opened 90 new positions and closed 52 in Q4 2025.
- Quinn Opportunity Partners's portfolio value rose 68% quarter-over-quarter to $2.37B.
Based on Quinn Opportunity Partners's 13F filing for Q4 2025, filed 13 Feb 2026.